Predicting preoperative muscle invasion status for bladder cancer using computed tomography-based radiomics nomogram
Authors:
Preprint
- 30 November 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Objectives The aim of the study is to assess the efficacy of the established computed tomography (CT)-based radiomics nomogram combined with radiomics and clinical features for predicting muscle invasion status in bladder cancer (BCa). Methods A retrospective analysis was conducted using data from patients who underwent CT urography at our institution between May 2018 and April 2023 with uroepithelial carcinoma of the bladder confirmed by postoperative histology. There were 196 patients enrolled in all, and each was randomized at random to either the training cohort (n = 137) or the test cohort (n = 59). 851 radiomics features in all were retrieved. For feature selection, the significance test and least absolute shrinkage and selection operator (LASSO) approaches were utilized. Subsequently, the radiomics score (Radscore) was obtained by applying linear weighting based on the selected features. The clinical and radiomics model, as well as radiomics-clinical nomogram were all established using logistic regression. Three models were evaluated using analysis of the receiver operating characteristic curve. An area under the curve (AUC) and 95% confidence intervals (CI) as well as specificity, sensitivity, accuracy, negative predictive value, and positive predictive value were included in the analysis. Radiomics-clinical nomogram's performance was assessed based on discrimination, calibration, and clinical utility. Results After obtaining 851 radiomics features, 12 features were ultimately selected. Histopathological grading and tortuous blood vessels were included in the clinical model. The Radscore and clinical histopathology grading were among the final predictors in the unique nomogram. The three models had an AUC of 0.811 (95% CI, 0.742–0.880), 0.845 (95% CI, 0.781–0.908), and 0.896 (95% CI, 0.846–0.947) in the training cohort and in the test cohort they were 0.808 (95% CI, 0.703–0.913), 0.847 (95% CI, 0.739–0.954), and 0.887 (95% CI, 0.803–0.971). According to the DeLong test, the radiomics-clinical nomogram's AUC in the training cohort substantially differed from that of the clinical model (AUC: 0.896 versus 0.845, p = 0.015) and the radiomics model (AUC: 0.896 versus 0.811, p = 0.002). The Delong test in the test cohort revealed no significant difference among the three models. The nomogram proved clinically useful, according to decision curve evaluations. Conclusions BCa muscle invasion status could be accurately predicted preoperatively by the radiomics-clinical nomogram.Keywords
All Related Versions
- Version 1, 2023-11-30, Research Square
- Published version: BMC Medical Imaging, 24 (1), 1.
This publication has 23 references indexed in Scilit:
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelEuropean Urology, 2021
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 GuidelinesEuropean Urology, 2021
- Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancerEuropean Radiology, 2019
- Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approachCancer, 2019
- Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumorsEuropean Radiology, 2019
- Quantitative Identification of Nonmuscle‐Invasive and Muscle‐Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics AnalysisJournal of Magnetic Resonance Imaging, 2018
- Upper and Lower Tract Urothelial Imaging Using Computed Tomography UrographyUrologic Clinics of North America, 2018
- High expression of insulin receptor on tumour‐associated blood vessels in invasive bladder cancer predicts poor overall and progression‐free survivalThe Journal of Pathology, 2017
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017